Pages that link to "Q50112659"
Jump to navigation
Jump to search
The following pages link to The effects of low-molecular-weight heparin at two different dosages on thrombin generation in cancer patients. A randomised controlled trial (Q50112659):
Displaying 6 items.
- Parenteral anticoagulation in ambulatory patients with cancer (Q22252972) (← links)
- A survey of thrombosis experts evaluating practices and opinions regarding venous thromboprophylaxis in patients with active cancer hospitalized with an acute medical illness (Q35114602) (← links)
- Anticoagulation for prevention and treatment of cancer-related venous thromboembolism. (Q38096441) (← links)
- The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials: comment (Q43453398) (← links)
- Parenteral anticoagulation in ambulatory patients with cancer. (Q47551857) (← links)
- Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update (Q51604439) (← links)